Can C-reactive protein/albumin ratio be a prognostic factor in acute stroke patients undergoing mechanical thrombectomy?
C-reactive protein (CRP) and albumin are markers synthesized by the liver and may reflect inflammatory responses. CRP/Albumin ratio (CAR) serves better to reflect the inflammatory state and therefore the prognosis. Worse prognosis is reported in previous studies when CAR rate on admission is high in...
Gespeichert in:
| Veröffentlicht in: | Clinical neurology and neurosurgery 2023-08, Vol.231, p.107856-107856, Article 107856 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 107856 |
|---|---|
| container_issue | |
| container_start_page | 107856 |
| container_title | Clinical neurology and neurosurgery |
| container_volume | 231 |
| creator | Akpınar, Cetin Kursad Kocaturk, Ozcan Aykac, Ozlem Acar, Bilgehan Atılgan Dogan, Hasan Onalan, Aysenur Acar, Turkan Uysal Kocabas, Zehra Topaktas, Berkhan Gurkas, Erdem Ozdemir, Atilla Ozcan |
| description | C-reactive protein (CRP) and albumin are markers synthesized by the liver and may reflect inflammatory responses. CRP/Albumin ratio (CAR) serves better to reflect the inflammatory state and therefore the prognosis. Worse prognosis is reported in previous studies when CAR rate on admission is high in patients with stroke, aneurysmal subarachnoid hemorrhage, malignancy or patients followed in intensive care units. We aimed to investigate the relation of CAR with prognosis in mechanical thrombectomy performed acute stroke patients.
Stroke patients admitted to five different stroke centers between January 2021 and August 2022 undergoing mechanical thrombectomy were included and retrospectively analyzed. The CAR ratio was calculated as the ratio of CRP to albumin level in the venous blood samples. Primary outcome was the relation between CAR and functional outcome at 90 days determined by modified Rankin Scale (mRS).
This study included 558 patients with a mean age of 66,5 ± 12.5 years (age range:18–89 years) best cutoff value of the CAR was 3.36, with 74.2 % sensitivity and 60.7 % specificity (Area under the curve: 0.774; 95 %CI: 0.693–0.794). There was no significant correlation between CAR rate and age, CAR rate and NIHSS on admission, and also between CAR rate and symptom recanalization (p > 0.05). CAR ratio in the mRS 3–6 group was statistically significantly higher (p |
| doi_str_mv | 10.1016/j.clineuro.2023.107856 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2835275912</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S030384672300272X</els_id><sourcerecordid>2844673897</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-34dfe0e893a777fa6bbb65ef898c3cb2efbceda9ab85c00b9c65e2ddfd46e75c3</originalsourceid><addsrcrecordid>eNqFkUFvFSEUhYnR2NfqX2hI3LiZVwZmgFmpeVFr0sSNrgkwd155zkAFpmn_vffltS7cuCLhfOdyOYeQy5ZtW9bKq8PWzyHCmtOWMy7wUuleviCbViveyEHql2TDBBON7qQ6I-elHBhjQkj9mpwJ1bVC835DHnY20l2Twfoa7oHe5VQhxCs7u3UJkWZbQ6IOqD1K-5hKDZ5OSKdMUbd-rUBLzekXmhGGWAtd4wh5n0Lc0wX8rY3B25nW25wWB2hdHj-8Ia8mOxd4-3RekJ9fPv_YXTc3379-2326abwYZG1EN07AQA_CKqUmK51zsodJD9oL7zhMzsNoB-t07xlzg0eVj-M0dhJU78UFeX-ai-v_XqFUs4TiYZ5thLQWw7XoueqHliP67h_0kNYccTukOoxR6EEhJU-Uz6mUDJO5y2Gx-dG0zBy7MQfz3I05dmNO3aDx8mn86hYY_9qey0Dg4wkAzOM-QDbFY574v5AxNTOm8L83_gB8Lqbf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2844673897</pqid></control><display><type>article</type><title>Can C-reactive protein/albumin ratio be a prognostic factor in acute stroke patients undergoing mechanical thrombectomy?</title><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Akpınar, Cetin Kursad ; Kocaturk, Ozcan ; Aykac, Ozlem ; Acar, Bilgehan Atılgan ; Dogan, Hasan ; Onalan, Aysenur ; Acar, Turkan ; Uysal Kocabas, Zehra ; Topaktas, Berkhan ; Gurkas, Erdem ; Ozdemir, Atilla Ozcan</creator><creatorcontrib>Akpınar, Cetin Kursad ; Kocaturk, Ozcan ; Aykac, Ozlem ; Acar, Bilgehan Atılgan ; Dogan, Hasan ; Onalan, Aysenur ; Acar, Turkan ; Uysal Kocabas, Zehra ; Topaktas, Berkhan ; Gurkas, Erdem ; Ozdemir, Atilla Ozcan</creatorcontrib><description>C-reactive protein (CRP) and albumin are markers synthesized by the liver and may reflect inflammatory responses. CRP/Albumin ratio (CAR) serves better to reflect the inflammatory state and therefore the prognosis. Worse prognosis is reported in previous studies when CAR rate on admission is high in patients with stroke, aneurysmal subarachnoid hemorrhage, malignancy or patients followed in intensive care units. We aimed to investigate the relation of CAR with prognosis in mechanical thrombectomy performed acute stroke patients.
Stroke patients admitted to five different stroke centers between January 2021 and August 2022 undergoing mechanical thrombectomy were included and retrospectively analyzed. The CAR ratio was calculated as the ratio of CRP to albumin level in the venous blood samples. Primary outcome was the relation between CAR and functional outcome at 90 days determined by modified Rankin Scale (mRS).
This study included 558 patients with a mean age of 66,5 ± 12.5 years (age range:18–89 years) best cutoff value of the CAR was 3.36, with 74.2 % sensitivity and 60.7 % specificity (Area under the curve: 0.774; 95 %CI: 0.693–0.794). There was no significant correlation between CAR rate and age, CAR rate and NIHSS on admission, and also between CAR rate and symptom recanalization (p > 0.05). CAR ratio in the mRS 3–6 group was statistically significantly higher (p < 0.001). In the multivariate analyses, CAR showed an association with 90-day mortality (odds ratio, 1.049; 95 % CI, 1.032–1.066)
In acute ischemic stroke patients treated with mechanical thrombectomy, CAR may be one of the factors affecting poor clinical outcome and/or mortality in patients undergoing mechanical thrombectomy. Upcoming similar studies in this patient group may better clarify the prognostic role of CAR.
•CAR value may be affecting poor clinical outcome and/or mortality.•CRP can use as a prognostic factor in patients with ischemic stroke.•The CRP/Albumin ratio (CAR) serves better to reflect the inflammatory state.</description><identifier>ISSN: 0303-8467</identifier><identifier>EISSN: 1872-6968</identifier><identifier>DOI: 10.1016/j.clineuro.2023.107856</identifier><identifier>PMID: 37413825</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Age ; Albumin ; Aneurysm ; Atherosclerosis ; Biomarkers ; Blood platelets ; C-reactive protein ; C-Reaktive Protein ; C-reaktive protein/albumin Ratio ; Cardiovascular disease ; Clinical outcomes ; Hemorrhage ; Inflammation ; Intensive care units ; Ischemia ; Lymphocytes ; Malignancy ; Mechanichal thrombectomy ; Medical prognosis ; Mortality ; Neurology ; Neutrophils ; Normal distribution ; Prognosis ; Prognostic factor ; Proteins ; Regression analysis ; Stroke ; Subarachnoid hemorrhage ; Tomography</subject><ispartof>Clinical neurology and neurosurgery, 2023-08, Vol.231, p.107856-107856, Article 107856</ispartof><rights>2023 Elsevier B.V.</rights><rights>Copyright © 2023 Elsevier B.V. All rights reserved.</rights><rights>2023. Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-34dfe0e893a777fa6bbb65ef898c3cb2efbceda9ab85c00b9c65e2ddfd46e75c3</citedby><cites>FETCH-LOGICAL-c396t-34dfe0e893a777fa6bbb65ef898c3cb2efbceda9ab85c00b9c65e2ddfd46e75c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2844673897?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37413825$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Akpınar, Cetin Kursad</creatorcontrib><creatorcontrib>Kocaturk, Ozcan</creatorcontrib><creatorcontrib>Aykac, Ozlem</creatorcontrib><creatorcontrib>Acar, Bilgehan Atılgan</creatorcontrib><creatorcontrib>Dogan, Hasan</creatorcontrib><creatorcontrib>Onalan, Aysenur</creatorcontrib><creatorcontrib>Acar, Turkan</creatorcontrib><creatorcontrib>Uysal Kocabas, Zehra</creatorcontrib><creatorcontrib>Topaktas, Berkhan</creatorcontrib><creatorcontrib>Gurkas, Erdem</creatorcontrib><creatorcontrib>Ozdemir, Atilla Ozcan</creatorcontrib><title>Can C-reactive protein/albumin ratio be a prognostic factor in acute stroke patients undergoing mechanical thrombectomy?</title><title>Clinical neurology and neurosurgery</title><addtitle>Clin Neurol Neurosurg</addtitle><description>C-reactive protein (CRP) and albumin are markers synthesized by the liver and may reflect inflammatory responses. CRP/Albumin ratio (CAR) serves better to reflect the inflammatory state and therefore the prognosis. Worse prognosis is reported in previous studies when CAR rate on admission is high in patients with stroke, aneurysmal subarachnoid hemorrhage, malignancy or patients followed in intensive care units. We aimed to investigate the relation of CAR with prognosis in mechanical thrombectomy performed acute stroke patients.
Stroke patients admitted to five different stroke centers between January 2021 and August 2022 undergoing mechanical thrombectomy were included and retrospectively analyzed. The CAR ratio was calculated as the ratio of CRP to albumin level in the venous blood samples. Primary outcome was the relation between CAR and functional outcome at 90 days determined by modified Rankin Scale (mRS).
This study included 558 patients with a mean age of 66,5 ± 12.5 years (age range:18–89 years) best cutoff value of the CAR was 3.36, with 74.2 % sensitivity and 60.7 % specificity (Area under the curve: 0.774; 95 %CI: 0.693–0.794). There was no significant correlation between CAR rate and age, CAR rate and NIHSS on admission, and also between CAR rate and symptom recanalization (p > 0.05). CAR ratio in the mRS 3–6 group was statistically significantly higher (p < 0.001). In the multivariate analyses, CAR showed an association with 90-day mortality (odds ratio, 1.049; 95 % CI, 1.032–1.066)
In acute ischemic stroke patients treated with mechanical thrombectomy, CAR may be one of the factors affecting poor clinical outcome and/or mortality in patients undergoing mechanical thrombectomy. Upcoming similar studies in this patient group may better clarify the prognostic role of CAR.
•CAR value may be affecting poor clinical outcome and/or mortality.•CRP can use as a prognostic factor in patients with ischemic stroke.•The CRP/Albumin ratio (CAR) serves better to reflect the inflammatory state.</description><subject>Age</subject><subject>Albumin</subject><subject>Aneurysm</subject><subject>Atherosclerosis</subject><subject>Biomarkers</subject><subject>Blood platelets</subject><subject>C-reactive protein</subject><subject>C-Reaktive Protein</subject><subject>C-reaktive protein/albumin Ratio</subject><subject>Cardiovascular disease</subject><subject>Clinical outcomes</subject><subject>Hemorrhage</subject><subject>Inflammation</subject><subject>Intensive care units</subject><subject>Ischemia</subject><subject>Lymphocytes</subject><subject>Malignancy</subject><subject>Mechanichal thrombectomy</subject><subject>Medical prognosis</subject><subject>Mortality</subject><subject>Neurology</subject><subject>Neutrophils</subject><subject>Normal distribution</subject><subject>Prognosis</subject><subject>Prognostic factor</subject><subject>Proteins</subject><subject>Regression analysis</subject><subject>Stroke</subject><subject>Subarachnoid hemorrhage</subject><subject>Tomography</subject><issn>0303-8467</issn><issn>1872-6968</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkUFvFSEUhYnR2NfqX2hI3LiZVwZmgFmpeVFr0sSNrgkwd155zkAFpmn_vffltS7cuCLhfOdyOYeQy5ZtW9bKq8PWzyHCmtOWMy7wUuleviCbViveyEHql2TDBBON7qQ6I-elHBhjQkj9mpwJ1bVC835DHnY20l2Twfoa7oHe5VQhxCs7u3UJkWZbQ6IOqD1K-5hKDZ5OSKdMUbd-rUBLzekXmhGGWAtd4wh5n0Lc0wX8rY3B25nW25wWB2hdHj-8Ia8mOxd4-3RekJ9fPv_YXTc3379-2326abwYZG1EN07AQA_CKqUmK51zsodJD9oL7zhMzsNoB-t07xlzg0eVj-M0dhJU78UFeX-ai-v_XqFUs4TiYZ5thLQWw7XoueqHliP67h_0kNYccTukOoxR6EEhJU-Uz6mUDJO5y2Gx-dG0zBy7MQfz3I05dmNO3aDx8mn86hYY_9qey0Dg4wkAzOM-QDbFY574v5AxNTOm8L83_gB8Lqbf</recordid><startdate>202308</startdate><enddate>202308</enddate><creator>Akpınar, Cetin Kursad</creator><creator>Kocaturk, Ozcan</creator><creator>Aykac, Ozlem</creator><creator>Acar, Bilgehan Atılgan</creator><creator>Dogan, Hasan</creator><creator>Onalan, Aysenur</creator><creator>Acar, Turkan</creator><creator>Uysal Kocabas, Zehra</creator><creator>Topaktas, Berkhan</creator><creator>Gurkas, Erdem</creator><creator>Ozdemir, Atilla Ozcan</creator><general>Elsevier B.V</general><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>202308</creationdate><title>Can C-reactive protein/albumin ratio be a prognostic factor in acute stroke patients undergoing mechanical thrombectomy?</title><author>Akpınar, Cetin Kursad ; Kocaturk, Ozcan ; Aykac, Ozlem ; Acar, Bilgehan Atılgan ; Dogan, Hasan ; Onalan, Aysenur ; Acar, Turkan ; Uysal Kocabas, Zehra ; Topaktas, Berkhan ; Gurkas, Erdem ; Ozdemir, Atilla Ozcan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-34dfe0e893a777fa6bbb65ef898c3cb2efbceda9ab85c00b9c65e2ddfd46e75c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Age</topic><topic>Albumin</topic><topic>Aneurysm</topic><topic>Atherosclerosis</topic><topic>Biomarkers</topic><topic>Blood platelets</topic><topic>C-reactive protein</topic><topic>C-Reaktive Protein</topic><topic>C-reaktive protein/albumin Ratio</topic><topic>Cardiovascular disease</topic><topic>Clinical outcomes</topic><topic>Hemorrhage</topic><topic>Inflammation</topic><topic>Intensive care units</topic><topic>Ischemia</topic><topic>Lymphocytes</topic><topic>Malignancy</topic><topic>Mechanichal thrombectomy</topic><topic>Medical prognosis</topic><topic>Mortality</topic><topic>Neurology</topic><topic>Neutrophils</topic><topic>Normal distribution</topic><topic>Prognosis</topic><topic>Prognostic factor</topic><topic>Proteins</topic><topic>Regression analysis</topic><topic>Stroke</topic><topic>Subarachnoid hemorrhage</topic><topic>Tomography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akpınar, Cetin Kursad</creatorcontrib><creatorcontrib>Kocaturk, Ozcan</creatorcontrib><creatorcontrib>Aykac, Ozlem</creatorcontrib><creatorcontrib>Acar, Bilgehan Atılgan</creatorcontrib><creatorcontrib>Dogan, Hasan</creatorcontrib><creatorcontrib>Onalan, Aysenur</creatorcontrib><creatorcontrib>Acar, Turkan</creatorcontrib><creatorcontrib>Uysal Kocabas, Zehra</creatorcontrib><creatorcontrib>Topaktas, Berkhan</creatorcontrib><creatorcontrib>Gurkas, Erdem</creatorcontrib><creatorcontrib>Ozdemir, Atilla Ozcan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical neurology and neurosurgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akpınar, Cetin Kursad</au><au>Kocaturk, Ozcan</au><au>Aykac, Ozlem</au><au>Acar, Bilgehan Atılgan</au><au>Dogan, Hasan</au><au>Onalan, Aysenur</au><au>Acar, Turkan</au><au>Uysal Kocabas, Zehra</au><au>Topaktas, Berkhan</au><au>Gurkas, Erdem</au><au>Ozdemir, Atilla Ozcan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Can C-reactive protein/albumin ratio be a prognostic factor in acute stroke patients undergoing mechanical thrombectomy?</atitle><jtitle>Clinical neurology and neurosurgery</jtitle><addtitle>Clin Neurol Neurosurg</addtitle><date>2023-08</date><risdate>2023</risdate><volume>231</volume><spage>107856</spage><epage>107856</epage><pages>107856-107856</pages><artnum>107856</artnum><issn>0303-8467</issn><eissn>1872-6968</eissn><abstract>C-reactive protein (CRP) and albumin are markers synthesized by the liver and may reflect inflammatory responses. CRP/Albumin ratio (CAR) serves better to reflect the inflammatory state and therefore the prognosis. Worse prognosis is reported in previous studies when CAR rate on admission is high in patients with stroke, aneurysmal subarachnoid hemorrhage, malignancy or patients followed in intensive care units. We aimed to investigate the relation of CAR with prognosis in mechanical thrombectomy performed acute stroke patients.
Stroke patients admitted to five different stroke centers between January 2021 and August 2022 undergoing mechanical thrombectomy were included and retrospectively analyzed. The CAR ratio was calculated as the ratio of CRP to albumin level in the venous blood samples. Primary outcome was the relation between CAR and functional outcome at 90 days determined by modified Rankin Scale (mRS).
This study included 558 patients with a mean age of 66,5 ± 12.5 years (age range:18–89 years) best cutoff value of the CAR was 3.36, with 74.2 % sensitivity and 60.7 % specificity (Area under the curve: 0.774; 95 %CI: 0.693–0.794). There was no significant correlation between CAR rate and age, CAR rate and NIHSS on admission, and also between CAR rate and symptom recanalization (p > 0.05). CAR ratio in the mRS 3–6 group was statistically significantly higher (p < 0.001). In the multivariate analyses, CAR showed an association with 90-day mortality (odds ratio, 1.049; 95 % CI, 1.032–1.066)
In acute ischemic stroke patients treated with mechanical thrombectomy, CAR may be one of the factors affecting poor clinical outcome and/or mortality in patients undergoing mechanical thrombectomy. Upcoming similar studies in this patient group may better clarify the prognostic role of CAR.
•CAR value may be affecting poor clinical outcome and/or mortality.•CRP can use as a prognostic factor in patients with ischemic stroke.•The CRP/Albumin ratio (CAR) serves better to reflect the inflammatory state.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>37413825</pmid><doi>10.1016/j.clineuro.2023.107856</doi><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0303-8467 |
| ispartof | Clinical neurology and neurosurgery, 2023-08, Vol.231, p.107856-107856, Article 107856 |
| issn | 0303-8467 1872-6968 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2835275912 |
| source | Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
| subjects | Age Albumin Aneurysm Atherosclerosis Biomarkers Blood platelets C-reactive protein C-Reaktive Protein C-reaktive protein/albumin Ratio Cardiovascular disease Clinical outcomes Hemorrhage Inflammation Intensive care units Ischemia Lymphocytes Malignancy Mechanichal thrombectomy Medical prognosis Mortality Neurology Neutrophils Normal distribution Prognosis Prognostic factor Proteins Regression analysis Stroke Subarachnoid hemorrhage Tomography |
| title | Can C-reactive protein/albumin ratio be a prognostic factor in acute stroke patients undergoing mechanical thrombectomy? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A38%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Can%20C-reactive%20protein/albumin%20ratio%20be%20a%20prognostic%20factor%20in%20acute%20stroke%20patients%20undergoing%20mechanical%20thrombectomy?&rft.jtitle=Clinical%20neurology%20and%20neurosurgery&rft.au=Akp%C4%B1nar,%20Cetin%20Kursad&rft.date=2023-08&rft.volume=231&rft.spage=107856&rft.epage=107856&rft.pages=107856-107856&rft.artnum=107856&rft.issn=0303-8467&rft.eissn=1872-6968&rft_id=info:doi/10.1016/j.clineuro.2023.107856&rft_dat=%3Cproquest_cross%3E2844673897%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2844673897&rft_id=info:pmid/37413825&rft_els_id=S030384672300272X&rfr_iscdi=true |